These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30604657)

  • 21. Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.
    Roalf DR; McDonald-McGinn DM; Jee J; Krall M; Crowley TB; Moberg PJ; Kohler C; Calkins ME; Crow AJD; Fleischer N; Gallagher RS; Gonzenbach V; Clark K; Gur RC; McClellan E; McGinn DE; Mordy A; Ruparel K; Turetsky BI; Shinohara RT; White L; Zackai E; Gur RE
    J Neurodev Disord; 2024 Jun; 16(1):35. PubMed ID: 38918700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome.
    Magnée MJ; Lamme VA; de Sain-van der Velden MG; Vorstman JA; Kemner C
    PLoS One; 2011; 6(10):e25882. PubMed ID: 21998713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMT implication in cognitive and psychiatric symptoms in chromosome 22q11 microdeletion syndrome: a selective review.
    Armando M; Papaleo F; Vicari S
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):273-81. PubMed ID: 22483289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
    Evers LJ; van Amelsvoort TA; Bakker JA; de Koning M; Drukker M; Curfs LM
    Psychopharmacology (Berl); 2015 Sep; 232(18):3319-25. PubMed ID: 26055684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.
    Solot CB; Moore TM; Crowley TB; Gerdes M; Moss E; McGinn DE; Emanuel BS; Zackai EH; Gallagher S; Calkins ME; Ruparel K; Gur RC; McDonald-McGinn DM; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):392-400. PubMed ID: 32715620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
    Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
    Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.
    Jalal R; Nair A; Lin A; Eckfeld A; Kushan L; Zinberg J; Karlsgodt KH; Cannon TD; Bearden CE
    J Neurodev Disord; 2021 Apr; 13(1):15. PubMed ID: 33863277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome.
    Montojo CA; Ibrahim A; Karlsgodt KH; Chow C; Hilton AE; Jonas RK; Vesagas TK; Bearden CE
    Neuroimage Clin; 2014; 4():392-402. PubMed ID: 24567911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moberg PJ; Yi JJ; Wiemken AS; Dress EM; Moore TM; Calkins ME; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE; Turetsky BI
    Schizophr Res; 2018 Dec; 202():113-119. PubMed ID: 30007867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms.
    Casarelli L; Minnei M; Pitzianti M; Armando M; Pontillo M; Vicari S; Pasini A
    Psychiatr Genet; 2016 Oct; 26(5):187-92. PubMed ID: 27548835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
    Armando M; Schneider M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
    PLoS One; 2017; 12(4):e0174797. PubMed ID: 28406913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder.
    Jalbrzikowski M; Lazaro MT; Gao F; Huang A; Chow C; Geschwind DH; Coppola G; Bearden CE
    PLoS One; 2015; 10(7):e0132542. PubMed ID: 26201030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
    Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
    Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: Autoimmune Psychosis in Chromosome 22q11.2 Deletion Syndrome.
    Ciano-Petersen NL; Hamad-Cueto O; Drissi-Reyes H; Doña-Díaz Á; García-Martín G
    Front Immunol; 2021; 12():708625. PubMed ID: 34721378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
    Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
    PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study.
    Pontillo M; Menghini D; Vicari S
    Schizophr Res; 2019 Jun; 208():76-81. PubMed ID: 31056275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.